130A Veritas In Silico
- 825
- -36-4.18%
Veritas In Silico News
Veritas In Silico: Patent owned by Veritas In Silico to Become Effective in Europe
Veritas In Silico: The entry into force of our patents within the European region
Veritas In Silico: Liverpool ChiroChem and VIS to Enter into a Collaboration Development & Commercialization Agreement for mRNA-targeted Small Molecule Drugs
Veritas In Silico: Announcement of the conclusion of a joint development and commercialization agreement for small molecule pharmaceuticals targeting mRNA with Liverpool ChiroChem in the UK
Veritas In Silico: Company Presentation
Veritas In Silico: Revised Financial Forecast for FY2024
Veritas In Silico: Explanatory materials on business plans and growth potential
Veritas In Silico: Notice regarding revisions to the full-year earnings forecast for the fiscal year ending 2024/12
Veritas In Silico: Organizational Reforms and Personnel Changes of General Managers
Veritas In Silico: Notice regarding organizational reforms and personnel changes (department manager level)
Veritas In Silico: Fiscal Year Ending December 2024, 3rd Quarter, Financial Results
Veritas In Silico: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/12
Veritas In Silico: Non-consolidated Financial Results for the Nine Months Ended September 30, 2024 [Under Japanese GAAP]
Veritas In Silico: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Veritas In Silico: Correction report (Large shareholding report / Change report)
Veritas In Silico: Mitsubishi Gas Chemical and Veritas In Silico, Sign MOU on Joint Business of Research and Development of RNA-Targeted Drugs
Veritas In Silico: Mitsubishi Gas Chemical and Veritas In Silico sign MOU for joint venture to develop pharmaceuticals targeting RNA
Veritas In Silico: Liverpool ChiroChem and Veritas In Silico Agree to Form a Strategic Partnership of mRNA-Targeted Drug Discovery and Development
Veritas In Silico: Notice of partnership agreement with Liverpool Chirochem in the UK regarding joint drug discovery business for small molecule drugs targeting mRNA
Veritas In Silico: Notification regarding Achievement of Milestone in Joint Drug Discovery Research with Shionogi & Co., Ltd.
No Data